Tallinn, Estonia–(Newsfile Corp. – February 19, 2022) – TrustRecruit presents the world’s first AI-enabled verified…
MALVERN, Pa., Feb. 18, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company…
MALVERN, Pa., Feb. 18, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage biopharmaceutical…
HERNDON, Va.–(BUSINESS WIRE)–#CRN–Iron Bow Technologies, an information technology solutions provider to government, commercial, education, and…
MIDDLETON, Wis.–(BUSINESS WIRE)–Spectrum Brands Holdings, Inc. (NYSE: SPB; “Spectrum Brands” or the “Company”), a leading…
SAN FRANCISCO–(BUSINESS WIRE)–NerdWallet, Inc. (NASDAQ: NRDS), a platform that provides financial guidance to consumers and…
KANSAS CITY, Mo.–(BUSINESS WIRE)–EPR Properties (NYSE: EPR) today announced that Lisa G. Trimberger and Caixia…
HAMILTON, Bermuda, Feb. 18, 2022 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today…
Orphazyme A/SCompany announcementNo. 06/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, February 18, 2022 – Orphazyme A/S…
New York, New York–(Newsfile Corp. – February 18, 2022) – The Meta Ruffy team has…
NANTES, France, Feb. 18, 2022 (GLOBE NEWSWIRE) — OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE)…
Data being presented at the 17th European Crohn’s and Colitis Organisation (ECCO) exhibit the use…
Las Vegas, Nevada–(Newsfile Corp. – February 18, 2022) – The Skill Integrity Council (the “Council”),…
DALLAS–(BUSINESS WIRE)–Energy Transfer LP (NYSE: ET) today announced it has filed its annual report on…
LONDON–(BUSINESS WIRE)–#KBRA–KBRA UK (KBRA) assigns preliminary ratings to six classes of notes issued by RRE…
NEW YORK–(BUSINESS WIRE)–MedReview, Inc., a leading provider of payment integrity, utilization management and quality surveillance…
SAN FRANCISCO–(BUSINESS WIRE)–#AI–Leading the transformation of BioPharma manufacturing, Aizon’s CEO and Board Member John Vitalie…
Powered by AI, DemandTec Autonomous Pricing enables retailers to maintain price perception and drive profitable…
HFS Research noted the “One Accenture” approach that enables Accenture to “bring together its breadth…
SEATTLE, Feb. 18, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company…